arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Immix Biopharma, Inc.

IMMX

$7.14 ▼ -0.83 (-10.35%) at close

24 Visible periods

25 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Immix Biopharma, Inc. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $455.3M

Dividend Yield —

Revenue Growth —

Op. Margin None

ROIC -5.4% ↗

FCF / Share $-0.18 ↘

Trailing P/E —

Price / Book 2.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

24-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-10.09M

↓ -52.3% —

FCF / Share Free cash flow per share

$-0.18

↓ -3.5% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.84x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	18.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-20.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-75.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	-46.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	31.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-4.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-22.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-109.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-118.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-80.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	95.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	8.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-83.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-52.3% Weak ↑ Weak Improving Year-over-year change in net income	-122.1% Weak ↓ Weak Declining Year-over-year change in net income	-122.1% Weak ↓ Weak Declining Year-over-year change in net income	-6.1% Weak ↑ Weak Improving Year-over-year change in net income	-50.8% Weak ↓ Weak Declining Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	5.5% Fair ↑ Fair Improving Year-over-year change in net income	-67.0% Weak ↓ Weak Declining Year-over-year change in net income	-22.8% Weak ↑ Weak Improving Year-over-year change in net income	-112.1% Weak ↑ Weak Improving Year-over-year change in net income	-33.9% Weak ↑ Weak Improving Year-over-year change in net income	-178.9% Weak ↓ Weak Declining Year-over-year change in net income	-168.5% Weak ↓ Weak Declining Year-over-year change in net income	-86.2% Weak ↓ Weak Declining Year-over-year change in net income	—	-51.0% Weak ↓ Weak Declining Year-over-year change in net income	-31.0% Weak Weak Year-over-year change in net income	-31.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	-201.7% Weak Weak Year-over-year change in free cash flow	—	—	—	66.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-17.0% Weak Weak Year-over-year change in free cash flow	—	—	—	-39.3% Weak Weak Year-over-year change in free cash flow	—	-598.3% Weak Weak Year-over-year change in free cash flow	—	-36.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-7.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-151%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-7.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-164%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-7.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-5.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	-42.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-8.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	5.6% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	2.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-21.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-3.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-4.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-12.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	—	—	—	—	—	-40.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-372%)	-18.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-223%)	-18.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-31.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-307%)	-21.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	-27.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-280%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-28.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	—	-7.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	—	16.4% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+9%)	17.4% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+16%)	17.8% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+19%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-14320.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3427.93x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.51x Weak Weak Operating income divided by interest expense Optimal: > 5x	-5.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-225.49M	$-79.25M	$-93.93M	$-15.95M	$-11.64M	$-15.92M	$-17.68M	$-19.69M	$-23.98M	$-29.32M	$-17.51M	$-19.58M	$-12.65M	$-11.46M	$-13.44M	—	$-18.40M	$-19.06M	$-17.64M	—	—	—	$-391.09K	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$1.44	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.18	$-0.18	$-0.28	$-0.24	$-0.22	$-0.15	$-0.16	$-0.24	$-0.15	$-0.22	$-0.24	$-0.23	$-0.24	$-0.18	$-0.27	$-0.11	$-0.11	$-0.10	$-6.16	$-0.12	$-0.06	$-0.30	—	—
Free Cash Flow per Share (USD)	$-0.18	$-0.18	—	$-0.20	—	$-0.06	—	—	—	$-0.18	—	—	—	$-0.15	—	$-0.11	—	$-0.11	—	$-0.02	$-0.05	$-0.08	—	—
Book Value per Share (USD)	$3.20	$1.59	—	—	—	—	—	$0.64	$0.87	$1.06	$0.82	$1.01	$0.81	$0.84	$0.95	—	$1.30	$1.42	—	$-1.84	$-1.73	$-1.69	$-1.40	—
Tangible Book Value per Share (USD)	$3.20	$1.59	—	—	—	—	—	$0.64	$0.87	$1.06	$0.82	$1.01	$0.81	$0.84	$0.95	—	$1.30	$1.42	—	$-1.84	$-1.73	$-1.69	$-1.40	—
Basic Weighted Avg Shares (shares)	63.77M	55.37M	—	31.93M	29.98M	29.70M	—	29.42M	28.79M	23.44M	—	18.58M	15.04M	13.90M	—	13.92M	13.88M	13.83M	—	3.38M	3.38M	3.38M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$224.49M	$81.74M	$91.13M	$5.73M	$2.32M	$7.47M	$11.51M	$16.19M	$23.43M	$27.26M	$16.07M	$19.51M	$13.11M	$11.56M	$13.62M	—	$18.11M	$19.65M	$17.98M	—	—	—	$-4.74M	—
Total Equity (USD)	$228.92M	$84.36M	—	—	—	—	—	$17.55M	$23.89M	$27.92M	$16.41M	$19.77M	$13.23M	$11.77M	$13.16M	—	$18.11M	$19.65M	—	$-6.20M	$-5.85M	$-5.71M	$-4.73M	$-3.65M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 8, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$20.00M	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$90.99K	$91.58K	$52.11K	$96.99K	—	$38.15K	$20.60K	—	—	$3.01K	$3.08K	—	—	$505.00	$566.00	$566.00	—	$620.00	$620.00	$620.00	$620.00	$608.00	—	—
Net Income, GAAP (USD)	$-10.09M	$-10.09M	$-10.69M	$-7.59M	$-6.62M	$-4.54M	$-4.81M	$-7.15M	$-4.39M	$-5.26M	$-5.09M	$-4.28M	$-3.58M	$-2.48M	$-3.80M	$-1.54M	$-1.33M	$-1.33M	—	$-1.02M	$-1.02M	$-1.02M	—	—
Operating Cash Flow (USD)	$-11.74M	$-9.83M	$-11.03M	$-5.91M	—	$-1.69M	$-1.48M	—	—	$-3.83M	$-2.68M	—	—	$-2.09M	$-3.90M	$-1.46M	—	$-1.49M	$-1.11M	$-50.76K	$-158.01K	$-266.45K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 24 quarters

Immix Biopharma, Inc.

Analytical Summary

24-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare IMMX with peers